March 5, 2020 / 2:14 PM / a month ago

BRIEF-Auris Medical Provides Update On Ongoing Clinical Trials With Intranasal Betahistine

March 5 (Reuters) - Auris Medical Holding Ltd:

* AURIS MEDICAL PROVIDES UPDATE ON ONGOING CLINICAL TRIALS WITH INTRANASAL BETAHISTINE

* AURIS MEDICAL HOLDING LTD - PHASE 2 TRIAL WITH AM-125 IN TREATMENT OF ACUTE PERIPHERAL VERTIGO PROGRESSING TOWARDS INTERIM ANALYSIS IN Q2 2020

* AURIS MEDICAL HOLDING LTD - FOR PHASE 1B TRIAL WITH AM-201, CO EXPECTS TO REPORT TOP-LINE DATA IN EARLY MAY 2020, IN ACCORDANCE WITH PREVIOUS GUIDANCE Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below